Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Schulman was appointed as Professor of Medicine, Associate Chair of Business Development and Strategy in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Economics at Stanford’s Graduate School of Business in June, 2018. Dr. Schulman is a Professor of Medicine, Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Operations, Information and Technology at Stanford’s Graduate School of Business. Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics. With over 300 original articles, over 100 review articles/commentaries, and over 40 case studies/book chapters, Kevin Schulman has had a broad impact on health policy (h-index = 77). His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Health Policy, Management and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Services Research. Prior to coming to Stanford, Dr. Schulman served as a Professor of Medicine at Duke University, directed the Health Sector Management Program at Duke’s Fuqua School of Business for a dozen years, created and directed the Duke University Master’s of Management in Clinical Informatics Program, and served as a Visiting Professor and Visiting Scholar at Harvard Business School.He is a co-founder of Bivarus (exit January, 2018), co-founder and Managing Member of Faculty Connection, LLC., and is a Board Member of Grid Therapeutics.He is an elected member of ASCI and AAP.He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program.